These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 327069)

  • 21. Antimutagenic effects of 2(3)-tert-butyl-4-hydroxyanisole and of antimicrobial agents.
    Batzinger RP; Ou SY; Bueding E
    Cancer Res; 1978 Dec; 38(12):4478-85. PubMed ID: 363261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the effect of Amoscanate on the immature stages of S. mansoni and S. haematobium worms in hamsters.
    Khalil SB; Girgis NI; Mansour NS
    J Egypt Soc Parasitol; 1986 Dec; 16(2):699-706. PubMed ID: 3097173
    [No Abstract]   [Full Text] [Related]  

  • 23. Mutagenic activities in vitro and in vivo of five antischistosomal compounds.
    Batzinger RP; Bueding E
    J Pharmacol Exp Ther; 1977 Jan; 200(1):1-9. PubMed ID: 319220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systolic time intervals in chronic anaemia before and after 4-isothiocyanato-4'-nitrodiphenylamine (C 9333-Go/CGP 4540). A new anthelmintic.
    Mankodi NA; Vaidya AB; Pillay MG; Nargunde HS; Paul T; Sheth UK; Kaul CL; Nair KG
    J Assoc Physicians India; 1981 Feb; 29(2):109-13. PubMed ID: 7263597
    [No Abstract]   [Full Text] [Related]  

  • 25. [Electron microscopic studies on the effect of nithiocyamine on Schistosoma japonica].
    Yu HZ; Lu M; Zhao KB; Wang P
    Yao Xue Xue Bao; 1983 Mar; 18(3):169-73. PubMed ID: 6880755
    [No Abstract]   [Full Text] [Related]  

  • 26. [Potentiation of pentobarbital hypnosis by nitrodiphenylaminoisothiocyanate].
    Tu ZG; Quan YZ
    Zhongguo Yao Li Xue Bao; 1983 Jun; 4(2):87-92. PubMed ID: 6225309
    [No Abstract]   [Full Text] [Related]  

  • 27. 4-Isothiocyanato-4'-nitrodiphenylamine (C 9333-Go/CGP 4540), an anthelminthic with an unusual spectrum of activity against intestinal nematodes, filariae and schistosomes.
    Striebel HP
    Experientia; 1976 Apr; 32(4):457-8. PubMed ID: 817928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chemotherapy of schistosomiasis.
    Archer S
    Annu Rev Pharmacol Toxicol; 1985; 25():485-508. PubMed ID: 3890709
    [No Abstract]   [Full Text] [Related]  

  • 29. Amoscanate as a topically applied chemical for prophylaxis against Schistosoma mansoni infections in mice.
    Greene LK; Grenan MM; Davidson DE; Jones DH; Shedd TR
    Am J Trop Med Hyg; 1983 Nov; 32(6):1356-63. PubMed ID: 6650736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current results in the clinical therapy of schistosomiasis mansoni.
    Katz N
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):8-17, 123-33. PubMed ID: 7006041
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutagenicity of sulfoscanate: a comparative study.
    Juneja TR; Talukdar A; Gupta RL
    Mutat Res; 2002 Jul; 518(2):155-61. PubMed ID: 12113767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapeutic effects of a nitrodiphenylaminoisothiocyanate (C9333-GO/CGP4540) on jirds infected with Brugia pahangi.
    Saz HJ; Dunbar GA; Bueding E
    Am J Trop Med Hyg; 1977 May; 26(3):574-5. PubMed ID: 869112
    [No Abstract]   [Full Text] [Related]  

  • 33. Protection by antibiotics against experimental focal cholangitis produced in mice by a schistosomicidal isothiocyanate.
    Batzinger RP; Bueding E; Popper H
    Hepatology; 1981; 1(1):21-7. PubMed ID: 7286888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schistosoma haematobium: amoscanate and adult worm ultrastructure.
    Leitch B; Probert AJ
    Exp Parasitol; 1984 Dec; 58(3):278-89. PubMed ID: 6500001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Salmonella typhimurium as a test system for detecting the mutagenic activity of environmental pollutants].
    Dugan AM
    Tsitol Genet; 1994; 28(3):37-41. PubMed ID: 7974781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation of mutagenic and other toxic properties from schistosomicides.
    Bueding E
    J Toxicol Environ Health; 1975 Nov; 1(2):329-34. PubMed ID: 1206775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The quantitative structure-activity relationship approach to the mutagenicity of N-nitrosomethylaniline compounds.
    Jinno K
    Mutat Res; 1984; 141(3-4):141-3. PubMed ID: 6392878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenic effect of 1.1'-hexamethylene-bis-[(5-p-chlorophenyl)-biguanide].
    Suessmuth R; Ackermann B; Lingens F
    Chem Biol Interact; 1979 Dec; 28(2-3):249-58. PubMed ID: 398749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 18. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report of a task group on mutagenic antischistosomals.
    Kramers PG; Gentile JM; Gryseels BJ; Jordan P; Katz N; Mott KE; Mulvihill JJ; Seed JL; Frohberg H
    Mutat Res; 1991 Jan; 257(1):49-89. PubMed ID: 1987457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Side effects on the nervous system caused by nithiocyamine. Clinical observation of 47 cases].
    Wu LS; Li F
    Zhonghua Nei Ke Za Zhi; 1983 Aug; 22(8):477-9. PubMed ID: 6653210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.